STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 99 filers reported holding STOKE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 1.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STATE STREET CORP | 586,008 | $2,308,872 | 0.00% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 29,789 | $118 | 0.00% |
| NEW YORK STATE COMMON RETIREMENT FUND | 10,688 | $42 | 0.00% |
| NISA INVESTMENT ADVISORS, LLC | 65 | $256 | 0.00% |
| MARSHALL WACE, LLP | 48,001 | $189,124 | 0.00% |
| AMERIPRISE FINANCIAL INC | 33,032 | $130,146 | 0.00% |
| DEUTSCHE BANK AG\ | 13,762 | $54,222 | 0.00% |
| CREDIT SUISSE AG/ | 12,449 | $49,049 | 0.00% |
| CITIGROUP INC | 600 | $2,364 | 0.00% |
| UBS ASSET MANAGEMENT AMERICAS INC | 11,398 | $44,908 | 0.00% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 217,339 | $856,316 | 0.00% |
| GOLDMAN SACHS GROUP INC | 129,305 | $509,462 | 0.00% |
| WELLINGTON MANAGEMENT GROUP LLP | 174,332 | $686,869 | 0.00% |
| AMALGAMATED BANK | 2,333 | $9 | 0.00% |
| BlackRock Inc. | 2,206,510 | $8,693,651 | 0.00% |
| Bank of New York Mellon Corp | 107,254 | $422,580 | 0.00% |
| Citadel Advisors | 1,200 | $4,728 | 0.00% |
| Nuveen Asset Management, LLC | 62,864 | $247,684 | 0.00% |
| Citadel Advisors | 76,120 | $299,913 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 72,241 | $284,630 | 0.00% |
External links
This page lists STOKE THERAPEUTICS INC's shareholders in Q3 2023. To view STOKE THERAPEUTICS INC's shareholder history, click here.